PathogenDx, an Arizona-based biotechnology company, has developed a disruptive testing technology for pathogen detection for the botanical, food, and Ag testing markets. The company entered into a national sales and distribution agreement with Emerald Scientific to supply it PDx-C Ultra-Rapid kit that can detect pathogens in less than 6 hours to testing labs focused on […]

BRISBANE, Calif. — CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant recipients, announces that it has signed an agreement with Illumina, Inc. (Nasdaq:ILMN) for the acquisition of Conexio SBT Resolver™ products and Assign™ SBT analysis software for high resolution HLA typing. SBT Resolver assay designs […]

New Addition to Patent Portfolio Strengthens Aushon’s Leadership Position in Microarray Technology Billerica, MA:  Aushon BioSystems – a leading provider of high sensitivity assays, instrumentation and services for multiplex quantitative detection of protein biomarkers, today announced US Patent No. 9,527,085 entitled “Apparatus and Method for Dispensing Fluid, Semi-Solid and Solid Samples” was issued by the U.S. […]

Solution offers research analysts the power to detect changes in glycosylation in a fraction of the time as traditional methods Framingham, MA — SCIEX, a global leader in life science analytical technologies, today announced the launch of the new Fast Glycan Labeling and Analysis Kit for quantitative glycan analysis in biopharmaceutical characterization. Research Analysts challenged by […]

The In-Fusion Cloning Primer Design Tool, powered by TeselaGen, generates primer sequences and vector maps Mountain View and San Francisco, CA—Takara Bio USA, Inc. (TBUSA, formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., today announced the launch of the In-Fusion Cloning Primer Design Tool, powered by TeselaGen Biotechnology, Inc. software. In-Fusion […]

SAN DIEGO and MELBOURNE, Australia and SPRINGFIELD, Va. — Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting technology, today announced a collaboration with Professor Melissa Little and the Murdoch Childrens Research Institute, The Royal Children’s Hospital, Melbourne, Australia to develop an architecturally correct kidney for potential therapeutic applications.  The collaboration has been made possible […]

Santa Clara, Calif. — Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554), and a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, announced its intention to significantly increase focus on the Life Science division of the organization. CrownBio’s Life Science division currently provides […]

U.S. Patent and Trademark Office finds U.S. Patent No. 8,658,430 invalid in inter partes review PLEASANTON, Calif. – 10x Genomics, Inc. today announced that the company has prevailed in an inter partes review proceeding before the U.S. Patent and Trademark Office to invalidate U.S. Patent No. 8,658,430 owned by RainDance Technologies, Inc. 10x initiated the proceeding after […]

Acquisition brings unprecedented scale and speed to organism design BOSTON — Ginkgo Bioworks, the organism company, announced today the acquisition of Gen9, a pioneer in the synthesis and assembly of DNA. The acquisition will bring Gen9’s unique expertise in assembling pathway-length synthetic DNA into Ginkgo’s automated organism engineering foundries, enabling improved speed and capacity in the […]

ROCHESTER, NY and ST LOUIS, MO – Adarza BioSystems, Inc., a leading next generation innovator in label-free, multiplex assays, announced today that it has closed a $17M Series C financing. Proceeds from the financing will be used to further expand production capacity in its St. Peters, MO manufacturing facility and fund final development and commercialization […]